Guidelines update, v41.1
15 July, 2021
Version 41.1 of the Australian guidelines for the clinical care of people with COVID-19 includes the identification of six new studies on disease-modifying treatments. Convalescent plasma - two new studies comparing convalescent plasma to usual care in 912 and 160 patients with moderate-critical COVID-19 (Bégin et al.), (Sekine et al.) Hydroxychloroquine - one new study comparing hydroxychloroquine to usual care...